Cargando…
Current Limitations and Recent Progress in Nanomedicine for Clinically Available Photodynamic Therapy
Photodynamic therapy (PDT) using oxygen, light, and photosensitizers has been receiving great attention, because it has potential for making up for the weakness of the existing therapies such as surgery, radiation therapy, and chemotherapy. It has been mainly used to treat cancer, and clinical tests...
Autores principales: | Park, Jooho, Lee, Yong-Kyu, Park, In-Kyu, Hwang, Seung Rim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7830249/ https://www.ncbi.nlm.nih.gov/pubmed/33467201 http://dx.doi.org/10.3390/biomedicines9010085 |
Ejemplares similares
-
Progress in Clinical Trials of Photodynamic Therapy for Solid Tumors and the Role of Nanomedicine
por: Alsaab, Hashem O., et al.
Publicado: (2020) -
Recent Advances in Photodynamic Therapy for Deep-Seated Tumors with the Aid of Nanomedicine
por: Li, Wei-Peng, et al.
Publicado: (2021) -
Recent advances in nanomedicines for photodynamic therapy (PDT)-driven cancer immunotherapy
por: Ji, Bin, et al.
Publicado: (2022) -
Clinical efficacy of photodynamic therapy
por: Park, Ye-Kyu, et al.
Publicado: (2016) -
Recent progress of hypoxia-modulated multifunctional nanomedicines to enhance photodynamic therapy: opportunities, challenges, and future development
por: Sun, Yixin, et al.
Publicado: (2020)